Synthetic Biologics Inc. (SYN) |
|
0.693 -0.019 (-2.74%)
|
03-25 14:11 |
|
Open: |
0.71 |
Pre. Close: |
0.7125 |
|
High:
|
0.7074 |
Low:
|
0.68 |
|
Volume:
|
163,884 |
Market Cap:
|
11M |
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.722 - 0.726 |
0.726 - 0.729 |
|
Low:
|
0.69 - 0.695 |
0.695 - 0.7 |
|
Close:
|
0.702 - 0.711 |
0.711 - 0.717 |
|
|
|
Technical analysis |
as of: 2019-03-25 2:03:06 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 0.89 One year: 0.99 |
| Support: |
Support1: 0.61 Support2: 0.51 |
| Resistance: |
Resistance1: 0.76 Resistance2: 0.85 |
| Pivot: |
0.71  |
| Moving Average: |
MA(5): 0.73  MA(20): 0.70
MA(100): 0.69 MA(250): 4.00 |
| MACD: |
MACD(12,26): 0.02 Signal(9): 0.02 |
| Stochastic oscillator: |
%K(14,3): 37.61 %D(3): 48.04 |
| RSI: |
RSI(14): 49.79 |
| 52-week: |
High: 12.95 Low: 0.51 Change(%): -94.6 |
| Average Vol(K): |
3-Month: 34665 10-Days: 73714 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.SYN has closed above bottom band by 40.5%. Bollinger Bands are 19.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 21 Nov 2018 21:26:55 Z
Health Care Sector Update for 11/21/2018: BPMC,CYAD,SYN,JNJ
Wed, 21 Nov 2018 20:07:08 Z
Health Care Sector Update for 11/21/2018: CYAD,SYN,JNJ
Wed, 21 Nov 2018 14:47:01 Z
Health Care Sector Update for 11/21/2018: SYN, CYAD, JNJ, PFE, ABT, MRK, AMGN
Wed, 21 Nov 2018 14:27:10 Z
Wall Street Set for Rebound Ahead of Thanksgiving
Wed, 21 Nov 2018 13:46:48 Z
US Futures Rebound Ahead of Thanksgiving
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
15.48 |
| Shares Float (M) |
9.97 |
|
% Held by Insiders
|
4.30 |
|
% Held by Institutions
|
18.90 |
|
Shares Short (K)
|
383 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-4.010 |
|
EPS Est. Current Year
|
-0.170 |
|
EPS Est. Next Year
|
-0.250 |
|
EPS Est. Next Quarter
|
-0.050 |
|
Forward EPS
|
1.#IO |
|
Book Value (p.s.)
|
0.990 |
|
PEG Ratio
|
|
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-103.3 |
|
Return on Equity (ttm)
|
-515.5 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-17.28 |
|
Levered Free Cash Flow (M)
|
-14.75 |
Stock Valuations |
|
P/E
|
-0.17 |
|
P/E Growth Ratio
|
-0.02 |
|
P/BV
|
0.70 |
|
P/S
|
|
|
P/CF
|
-0.62 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
2018-08-13 |
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
